» Articles » PMID: 31315417

Age-Related Effect of Antihypertensive Treatment on Cognitive Performance: Is It Better Preventing Dementia in Older Age?

Overview
Publisher Sage Publications
Specialty Neurology
Date 2019 Jul 19
PMID 31315417
Citations 3
Authors
Affiliations
Soon will be listed here.
Abstract

The aim of this study is to investigate the impact of optimal antihypertensive medication on cognitive function. In this 6-month clinical trial, 248 adults were randomly selected by a registry of hypertensive-treated patients (based on a National Hypertension Treatment Program), followed health centers located in Rafsanjan County, Southeast, Iran. Blood pressure was measured 3 times in each appointment pre- and posttreatment. Mini-Mental State Examination was used for cognitive performance evaluation. Paired test and multiple regression model showed significant correlation between "the differences of systolic and diastolic blood pressure levels" and "cognitive performance in treated patients more than 40 years old." Cognitive performance was not significantly different in patients less than 40 years old post antihypertensive treatment. Cognitive performance scores demonstrated significant increase in responders more than 40 years old post antihypertensive treatment. Antihypertensive treatment in responders with age equal or more than 40 years improves the level of cognitive performance significantly.

Citing Articles

Biological Risk Factors Influencing Vascular Cognitive Impairments: A Review of the Evidence.

Ilut S, Vesa S, Vacaras V, Braita L, Dascalescu V, Fantu I Brain Sci. 2023; 13(7).

PMID: 37509024 PMC: 10377134. DOI: 10.3390/brainsci13071094.


Factors associated with cognitive impairment in Latin American older adults: A cross-sectional observational study of COVID-19 confinement.

Ramos-Henderson M, Soto-Anari M, Herrera-Pino J, Porto M, Camargo L, Hesse H Alzheimers Dement (Amst). 2023; 15(2):e12427.

PMID: 37063389 PMC: 10102893. DOI: 10.1002/dad2.12427.


The Association Between Hypertension and Cognitive Impairment, and the Role of Antihypertensive Medications: A Literature Review.

Mishra N, Mohan D, Fuad S, Basavanagowda D, Alrashid Z, Kaur A Cureus. 2021; 12(12):e12035.

PMID: 33457135 PMC: 7797448. DOI: 10.7759/cureus.12035.

References
1.
Wiysonge C, Bradley H, Mayosi B, Maroney R, Mbewu A, Opie L . Beta-blockers for hypertension. Cochrane Database Syst Rev. 2007; (1):CD002003. DOI: 10.1002/14651858.CD002003.pub2. View

2.
Tzourio C, Dufouil C, Ducimetiere P, Alperovitch A . Cognitive decline in individuals with high blood pressure: a longitudinal study in the elderly. EVA Study Group. Epidemiology of Vascular Aging. Neurology. 1999; 53(9):1948-52. DOI: 10.1212/wnl.53.9.1948. View

3.
Powers B, Olsen M, Smith V, Woolson R, Bosworth H, Oddone E . Measuring blood pressure for decision making and quality reporting: where and how many measures?. Ann Intern Med. 2011; 154(12):781-8, W-289-90. DOI: 10.7326/0003-4819-154-12-201106210-00005. View

4.
Bradley H, Wiysonge C, Volmink J, Mayosi B, Opie L . How strong is the evidence for use of beta-blockers as first-line therapy for hypertension? Systematic review and meta-analysis. J Hypertens. 2006; 24(11):2131-41. DOI: 10.1097/01.hjh.0000249685.58370.28. View

5.
Harrington F, Saxby B, McKeith I, Wesnes K, Ford G . Cognitive performance in hypertensive and normotensive older subjects. Hypertension. 2000; 36(6):1079-82. DOI: 10.1161/01.hyp.36.6.1079. View